共 58 条
[1]
Johnson M., Et al., Paediatric acute-onset neuropsychiatric syndrome in children and adolescents: an observational cohort study, Lancet Child Adolesc. Health, 3, pp. 175-180, (2019)
[2]
Gromark C., Et al., Establishing a pediatric acute-onset neuropsychiatric syndrome clinic: baseline clinical features of the pediatric acute-onset neuropsychiatric syndrome Cohort at Karolinska Institutet, J. Child Adolesc. Psychopharmacol, 29, (2019)
[3]
Frankovich J., Et al., Multidisciplinary Clinic dedicated to treating youth with pediatric acute-onset neuropsychiatric syndrome: presenting characteristics of the first 47 consecutive patients, J. Child Adolesc. Psychopharmacol, 25, (2015)
[4]
Swedo S.E., Leckman J.F., Rose N.R., From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome), Pediatr. Ther, 2, (2012)
[5]
Pfeiffer H.C.V., Et al., Clinical guidance for diagnosis and management of suspected pediatric acute-onset neuropsychiatric syndrome in the Nordic countries, Acta Paediatr, pp. 1-8, (2021)
[6]
Gromark C., Et al., A two-to-five year follow-up of a pediatric acute-onset neuropsychiatric syndrome Cohort, Child Psychiatry Hum. Dev, 53, pp. 354-364, (2022)
[7]
Johnson M., Et al., Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): a systematic review, PLoS One, 16, (2021)
[8]
Bigi S., Licht C., Twilt M., Benseler S.M., OP70–2417: plasma exchange (PLEX) in pediatric neurologic diseases: assessment of safety and efficacy, Eur. J. Paediatr. Neurol, 19, (2015)
[9]
Guo Y., Tian X., Wang X., Xiao Z., Adverse effects of immunoglobulin therapy, Front. Immunol, 9, (2018)
[10]
Sorg E.M., Chaney-Catchpole M., Hazen E.P., Pediatric catatonia: a case series-based review of presentation, evaluation, and management, Psychosomatics, 59, pp. 531-538, (2018)